Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931

Annals of Oncology(2025)10.1016/j.annonc.2025.07.004Source: DataRank Database

Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931 is a research paper published in Annals of Oncology (2025). On theSindex it has a DataRank of 0.360. It has been cited 10 times.

N/A

0.360DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Free full text

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 8.21)OA: greenTopics (41)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.360

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (17)

Michael Luu ORCID,Catherine Fortpied ORCID,Jong Keon Jang ORCID,Meimei Chen ORCID,Jon Mallen‐St. Clair ORCID

Live enrichment

PubMed:40680992 OpenAlex:https://openalex.org/W4412522764

National Institutes of Health

Grant: EORTC 22931

National Institutes of Health National Cancer Institute

Grant: U10CA180868

National Institutes of Health National Cancer Institute

Grant: U10CA180822

NCI NIH HHS

Grant: U10 CA011488

FWCI

8.21

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12376881/

publisherhttps://api.elsevier.com/content/article/PII:S0923753425008531?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0923753425008531?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.annonc.2025.07.004

Fields of Study

Head and Neck Cancer StudiesOral health in cancer treatmentAdvanced Radiotherapy TechniquesHumansHead and Neck NeoplasmsMaleFemaleMiddle AgedAgedChemoradiotherapyNeoplasm Recurrence, LocalAdultFollow-Up StudiesSquamous Cell Carcinoma of Head and NeckRandomized Controlled Trials as Topic

MeSH Terms

Squamous Cell Carcinoma of Head and NeckAdultAgedFemaleFollow-Up StudiesHead and Neck NeoplasmsHumansMaleMiddle AgedNeoplasm Recurrence, LocalRandomized Controlled Trials as TopicChemoradiotherapy

Keywords

MedicineChemoradiotherapyInternal medicineOncologyPost-hoc analysisProportional hazards modelHead and neck cancerSubgroup analysisRadiation therapyRandomized controlled trialSurvival analysisConfidence intervalChemoradiationPost-operative

Sustainable Development Goals

SDG 0: Good health and well-being